Penumbra, Inc.

NYSE:PEN

Medical - Devices

Healthcare
$320.60 -0.72%

-$2.30 today

Market cap
$12.64B
Beta
0.70
P/E (TTM)
72.6
EPS (TTM)
$4.36
52W Low $221.26High $362.41

Volume 0.21M

Average 0.50M

PEN Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Penumbra, Inc.NYSE: PEN

Weighted Avg Shares · Q2 FY2026 · quarter ended Jun 2026

Weighted avg shares grows in line with its trailing trend

Q2 FY2026 weighted avg shares of 39.31M shares rose 1.2% year over year, in line with the +1.4% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.1% from the prior quarter. Over 3 fiscal years it compounded at +0.9% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +1.2% toward the trailing-twelve-month pace of +1.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
39.31M+0.1% QoQ
Last fiscal yearDec 2025
38.92M+0.7% YoY
LTMJun 2026
39.21M+1.4% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1.2%——
1 year+0.7%——
3-year CAGR+0.9%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
38.92M USD
Year-over-year change
+0.7%
4-year CAGR
+1.4%

Weighted Avg Shares vs competitors

How PEN compares with its peers on the latest reported figures

  • PEN's LTM Jun 2026 weighted avg shares of 39.21M shares is the 8th highest of the 9 companies compared; the peer median is 466.75M shares.
  • Its year-over-year change of +1.4% is the highest of 9, against a peer median of +0.3%.
  • Over three fiscal years its annual growth of +0.9% compares with a peer median of +0.6%.
PEN Competitors Peer median
Weighted Avg Shares for PEN and competitors
Company Period LTM YoY 3-year CAGR
ABTAbbott LaboratoriesLTM Sep 20261.74B +0.1%-0.1%
BSXBoston Scientific CorporationLTM Jun 20261.48B +0.4%+1.1%
MDTMedtronic plcLTM Jul 20261.28B -0.1%-1.2%
EWEdwards Lifesciences CorporationLTM Jun 2026580.18M -1.7%-1.9%
ISRGIntuitive Surgical, Inc.LTM Sep 2026353.33M -1.1%+0.1%
MMSIMerit Medical Systems, Inc.LTM Sep 202659.58M +1.1%+1.4%
ANGOAngioDynamics, Inc.LTM Feb 202641.29M +1.4%+1.7%
PENPenumbra, Inc.LTM Jun 202639.21M +1.4%+0.9%
LMATLeMaitre Vascular, Inc.LTM Mar 202622.7M +0.9%+1.0%
Peer median (excluding PEN) 466.75M+0.3%+0.6%

Competitors are the stored peer set for PEN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue747.59M847.13M1.06B1.19B1.4B
Cost of Revenue272.21M311.93M375.88M439.62M461.23M
Gross Profit475.38M535.21M682.64M755M942.44M
Gross Margin63.6%63.2%64.5%63.2%67.1%
Research & Development104.55M79.41M84.42M94.78M89.77M
Selling, General & Admin378.33M449.72M506.45M573.99M663.42M
Operating Expenses482.88M529.13M609.09M668.77M753.19M
Depreciation & Amortization16.41M24.32M27.26M23.7M17.47M
EBITDA7.84M29.96M108.65M45.99M223.91M
EBITDA Margin1.0%3.5%10.3%3.8%16.0%
Operating Income(7.5M)6.08M73.55M86.22M189.25M
Operating Margin-1.0%0.7%6.9%7.2%13.5%
Interest Income2.87M1.89M6.83M13.69M16.29M
Interest Expense1.93M1.75M1.74M1.42M1.31M
Other Income / Expenses(3M)(2.19M)6.1M(65.36M)15.88M
Income Before Tax(10.5M)3.89M79.65M20.87M205.13M
Pre-Tax Margin-1.4%0.5%7.5%1.7%14.6%
Income Tax Expense(13.13M)5.89M(11.3M)6.86M27.44M
Net Income5.28M(2M)90.95M14.01M177.69M
Net Margin0.7%-0.2%8.6%1.2%12.7%
EPS (Basic)0.14(0.05)2.370.364.57
EPS (Diluted)0.14(0.05)2.320.364.52
Weighted Avg Shares36.76M37.84M38.4M38.63M38.92M
Weighted Avg Shares (Diluted)37.88M37.84M39.22M39.27M39.29M

Penumbra, Inc.

NYSE:PEN

Intrinsic Alpha fair value

Locked

Current Price

$320.60

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.